Podcasts about patients

Today's episode of Out of Patients welcomes Dr Pamela Buchanan, an emergency room physician with over 20 years inside American medicine who refuses to sugarcoat what the job demands and what it destroys. She worked straight through COVID as protocols changed by the day and deaths arrived faster than anyone could process. She logged 80 to 100 hour weeks. She isolated from her family to avoid bringing the virus home. Over time, survival began to feel negotiable.Dr Buchanan speaks openly about burnout as emotional flatline and about physician suicide as a predictable outcome that leadership prefers to ignore. She describes the ER as the catch all for a broken system and explains why chronic care collapses there by design. She shares the reality of trying to access mental health care while still practicing medicine, calling dozens of therapists, getting nowhere, and spending $10,000 to $15,000 out of pocket just to stay alive and functional.Listeners will hear how neurodivergence shaped her career in emergency medicine, how race and trust intersect inside hospital walls, and why doctors are leaving in waves. This conversation carries clarity, anger, humor, and hard earned truth from someone who stayed long enough to name the damage.RELATED LINKSDr Pamela BuchananStrong MedicineDr Pamela Buchanan on LinkedInDr Pamela Buchanan on InstagramEmotional Flatline articleKevinMD essay by Dr Pamela BuchananFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Send a text

In this episode, fertility expert Gabriela Rosa reveals one of the biggest blind spots in modern fertility care: many couples are pushed toward treatments like IVF before receiving a true diagnosis. She breaks down how fertility clinics often operate, why infertility is frequently misunderstood, and how underlying issues such as thyroid dysfunction, insulin resistance, and PCOS can significantly impact reproductive outcomes. Gabriela shares powerful patient stories, including Renee's own experience, to illustrate how personalized investigation and root-cause medicine can dramatically shift fertility trajectories. She also explains why fertility is a “team sport,” outlining her strategic approach to improving egg quality, hormonal balance, and metabolic health while interpreting key tests like AMH and follicle development timelines. The conversation concludes with practical guidance on nutrition's role in fertility, her “Three Rocks” framework for treatment, and a thoughtful decision tree to help women determine when egg freezing may or may not be the right choice. Gabriela Rosa, DrPH (Candidate, Harvard), is a Harvard-awarded fertility specialist, founder of The Rosa Institute, and author of Fertility Breakthrough: Overcoming Infertility and Recurrent Miscarriage When Other Treatments Have Failed. She pioneered telehealth-based, integrative fertility care, making evidence-based solutions accessible worldwide.Gabriela also created and hosts The Fertility Challenge, a free online program that reaches tens of thousands globally each year. Her F.E.R.T.I.L.E. Method® has supported more than 204,000 people across 111 countries, with published research demonstrating a 78.8% live birth rate among patients in her signature program—even after years of infertility, recurrent miscarriage, and failed treatments.SHOW NOTES:0:39 Welcome to the show!2:43 About Gabriela Rosa3:35 Welcome her to the podcast!4:47 The biggest blindspot in fertility9:05 How fertility clinics operate10:56 What does infertility mean?11:52 Getting a proper diagnosis12:36 Patient story16:26 IVF industry goals18:48 Miscarriage & Thyroid21:19 Renee's story23:35 IUI incentives & results25:19 Who benefits from IVF?27:50 *APOLLO NEURO*29:50 *CALOCURB*31:00 Who gets turned away from her clinic35:39 Who she does work with37:30 Fertility is a team sport40:05 Her strategy for improving fertility43:16 Timeline of eggs & follicles45:45 AMH testing & optimal ranges51:14 PCOS & Insulin Resistance55:04 Infertility and all-cause mortality1:01:03 Research on correlation between nutrition & fertility1:05:38 The 3 Rocks1:11:09 Egg Freezing decision treeRESOURCES:Apollo Neuro - code: BIOHACKERBABES for $90 offCalocurb - code: RENEE10Website: fertilitybreakthrough.comIG: @dr.gabrielarosa, @fertilitybreakthroughFB: FertilitySpecialistGabrielaRosaX: gabrielarosaTikTok: @gabrielarosafertilityPodcast: Talk Sex with Gabriela RosaSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

In the first episode of 4theRecord, Tyler Kemp of Marketing4ECPs explores what it takes to build a memorable brand patients trust. Joined by Sarah Nwaerondu and Kevin Wilhelm, the conversation highlights how consistency, emotional connection, and patient experience help eye care practices stand out and grow.

God's patience is far greater than we often expect. In this parable, Jesus shows a God who tends, nurtures, and gives space for repentance and growth. Yet patience is not permission to remain unchanged. God's kindness invites a response that leads to real transformation and lasting fruit.⚫CONNECT WITH US:

Dans cet épisode de Cheminements enregistré en public, nous explorons une aventure collective qui fait bouger les lignes de la prévention solaire. Comment passer des discours médicaux classiques à une communication qui "passe crème" auprès des jeunes ? À travers trois projets concrets. Du programme Student Voices au jeu de 7 familles pédagogique, jusqu'à l'outil MySun Experience, nos invitées dévoilent les coulisses d'une collaboration inédite entre une association de patients et un laboratoire dermatologique. Un échange riche sur l'importance de la co-construction pour transformer des messages de santé en véritables réflexes de vie.Les intervenantes :Pascale Benaksas : présidente de l'association France Assos Cancer et Peau, patiente engagée pour le dépistage précoce.Céline Decarpigny : chef de projet expérience patient au sein du Groupe Pierre Fabre.Catherine Baissac : docteur en pharmacie et responsable expérience patient (Patient Advocacy) chez Pierre Fabre.Les sujets abordés dans l'épisode :Les nouveaux codes de communication : pourquoi parler de vieillissement cutané et d'esthétique touche plus les jeunes que le discours sur le cancer.L'effet "daronne" : comprendre les freins psychologiques et sociaux à l'application de la crème solaire entre amis.Le danger des cabines UV : le combat pour l'interdiction des "machines à cancer" en France.Le jeu comme outil de soin : comment un jeu de 7 familles peut transformer les enfants en ambassadeurs de la prévention.L'algorithme du vieillissement : présentation de MySun Experience, l'outil qui calcule l'impact réel de vos habitudes solaires sur votre peau dans 15 ans.Crédits :Écriture : Marguerite de RodellecProduction : MedShake StudioCet épisode à été enregistré durant la première édition de la Journée Patients & Pharma, un événement pour créer un véritable espace de dialogue entre représentants de patients et industrie qui a eu lieu le 4 décembre 2025, à la Maison A. Trocadéro. Chers auditeurs, je vous informe que d'autres épisodes exclusifs du podcast Cheminements ont été enregistrés en direct, pour donner la parole à des binômes patients / laboratoires qui sont venus raconter leurs collaborations, leurs défis, et parfois même… leurs histoires d'amour professionnelles. Alors si ce sujet vous parle, rejoignez-nous.Ressources :https://patientspharma.com/En ouvrant le dictionnaire, on apprend que "cheminement" désigne une progression graduelle, un mouvement, une avance graduelle.➡ Retrouvez tous les épisodes sur https://www.cheminements.co/❤️ Soutenez-nous gratuitement :Abonnez-vous !Laissez 5 étoiles et un avis sur Apple Podcasts ou Spotify ⭐Cheminements, le podcast santé des femmes, dans vos oreilles chaque semaine.Hébergé par Ausha. Visitez ausha.co/politique-de-confidentialite pour plus d'informations.

"This came from an experience with a patient. It was early in my analytic training, and I was working with a supervisor who I really admired, and worked with her for a number of years. She was post-Kleinian, and was great at interpretation, formulation, and she was really helpful with just starting to guide me towards a lot of this work. I remember describing to her a patient session, and I was going through my process notes, and I said, 'I feel like the patient is inside of me. I feel like they want something that's in me, and I don't know what it is, and I can't quite access my own self, I don't know what to do'. It was through this initial experience where I really felt why analytic training versus other less intense training, we were also right at the time doing infant development, offered so much. It was early in my training and she suggested I think about an infant or even a toddler when they want something from their parents - they want something from their mother. The mother kind of feels this kind of gripping or this yearning from them, the baby wanting something. I started to think of my patients, not as infants or babies, but that what I was feeling was that there was something that the person I was working with needed, and they didn't have words yet to tell me what that was."    Episode Description: We begin by recognizing the unique journeys that lead clinicians to become psychoanalysts. Pam shares with us her initial exposure to dynamic thinking but felt that she was missing some awareness of what was happening in herself and in the patients she was working with - "I was curious...I wanted to go deeper, to know more." This led her to enroll in full-time analytic training. She shares with us her understanding of the 'difficult to reach patients' that she was treating and presents a fictionized case that represents the many countertransference struggles she faced. She noted that "instead of the patient realizing that she wanted something from me, she instead felt attacked by me." Supervision was essential in helping her make sense of her experiences and of learning to 'listen to the music'. We close by noting her open-ended curiosity and interest in learning more - lifelong attributes of analysts who continue to take pleasure in our work.   Our Guest: Pamela Polizzi, LCSW maintains a full-time private practice in New York City. She specializes in working with patients struggling with eating disorders, complex personality struggles, anxiety, depression, relational trauma, and life transitions. She earned her Master of Social Work (MSW) in Advanced Standing Clinical Practice from Fordham University at Lincoln Center in 2011. Currently, she is an Advanced Candidate at the Psychoanalytic Training Institute of the Contemporary Freudian Society (CFS) in Manhattan, working toward becoming a psychoanalyst. She completed a 2015 Two-Year Advanced Psychodynamic Psychotherapy Certificate in the Integrated Treatment of Eating Disorders from the Institute of Contemporary Psychotherapy (ICP), Center for the Study of Anorexia and Bulimia (CSAB). She also completed the Contemporary Freudian Society's (CFS) Two-Year Psychoanalytic Psychotherapy Program in 2019.  Recommended Readings: Readings for Psychoanalytic Candidates:  Bach, S. (2011). The How-To Book For Students of Psychoanalysis and Psychotherapy. Karnac.   Busch, F. (2021). Dear Candidates: Analysts From Around The World Offer Personal Reflections on Psychoanalytic Training, Education, and The Profession. Routledge.    Readings on Clinical Practice with the Patient who is Difficult to Reach:   Bollas, C. (1996). Borderline Desire. Int. Forum Psychoanal., (5)(1):5-9.   Joseph. B., Feldman, M., & Spillius, M. (1989). Psychic Equilibrium and Psychic Change: Selected Papers of Betty Joseph. New Lib. of Psycho-Anal., (9):1-222. (on Pep-web).  Joseph, B. (1975) The patient who is difficult to reach.  Joseph, B. (1982) Addiction to near-death.  Joseph, B. (1983) On understanding and not understanding: some technical issues.  Riesenberg-Malcolm, R. (1999). On Bearing Unbearable States of Mind. Routledge.    Steiner, J. (1993). Psychic Retreats: Pathological Organizations in Psychotic, Neurotic and Psychotic Patients. Routledge.    Winnicott, D.W. (1974). Fear of Breakdown. Int. R. of Psycho-Analysis. 1: 103-107.

Patients want clearer pricing, clinics want operational sustainability, managed care wants predictable cost control……and everyone wants more transparency.This epiosde centers on the groundbreaking Journal of Assisted Reproduction and Genetics (JARG) paper on Activity-Based Costing in IVF and what it actually costs.We're joined by Pinnacle CFO Shruti Sood, The Fertility Partners CEO Heather Stark, and Chartis Partner Bret Anderson to discuss:Why IVF costs have not been accurately accounted forHow activity-based costing could reshape pricing modelsThe real impact of payer consolidationWhere clinics confuse capacity problems with volume problemsWhether different prognosis patients should be priced differentlyHow managed care pressure will change IVF economics

Send a textWhat if the biggest driver of a healthy pregnancy isn't found in a chart, but in a bus schedule, a work shift, or a zip code? In this episode, Cara and Missi pull back the curtain on social determinants of health and talk candidly about why late or no prenatal care rarely means a patient doesn't care—and how midwives can meet these barriers head-on.We break down the big five domains—economic stability, education, healthcare access, neighborhood and environment, and social context—and connect them to preterm birth, preeclampsia, and low birth weight. You'll hear real stories from triage to community clinics that reveal why “proximity” isn't the same as “access,” how immigration fears suppress visits, and how chronic stress leaves a physiologic mark. Then we get tactical: validated screening tools like PRAPARE and the AAFP Social Needs Screening Tool, the three fast questions that catch most needs, and scripts that normalize sensitive topics without stigma.From there, we move into action. Warm handoffs, bedside calls, and referrals that put the follow-up burden on the system—not the patient—turn intentions into impact. We dig into practical documentation with Z codes that make populations visible, and we frame advocacy as a clinical skill that spans workplace notes, hospital policy, and conversations with legislators. Along the way, we draw a bright line between equality and equity and share simple ways to right-size support: flexible hours, interpreters, transportation help, and trauma-informed consent.If you're ready to turn empathy into outcomes, this conversation will give you tools you can use on your next shift. Subscribe, share with a colleague, and leave a review with the biggest barrier you see in your community—and how you're tackling it.

Today, we're putting The Tonearm's needle on Michael Graves, a five-time Grammy-winning mastering engineer and the founder of Osiris Studio in Los Angeles.Michael's work is restoration as archaeology—pulling performances off deteriorating tapes, damaged acetates, and obsolete formats, then deciding how much intervention is too much. He's done this for recordings by Hank Williams, Aretha Franklin, Stax songwriters, and field recordings from Cambodia, Sudan, and Mississippi. His most recent Grammy came in 2024 for Written in Their Soul: The Stax Songwriter Demos.The deeper question his work raises is curatorial: where does restoration end and revisionism begin? What gets rescued, and what stays buried?—Dig Deeper• Michael Graves and Osiris Studio:Visit Michael Graves at osirisstudio.com and follow Osiris Studio on InstagramMichael Graves — Osiris Studio: AboutMichael Graves (sound engineer) — Wikipedia• Key Projects Discussed:Written in Their Soul: The Stax Songwriter Demos — 7-CD box set on Craft Recordings (2023), Grammy Award for Best Historical Album (2024)Blondie: Against the Odds: 1974–1982 — box set via Numero Group and UMe (2022)Chris Bell: I Am the Cosmos — definitive reissue on Omnivore Recordings (2017)Chris Bell: The Complete Chris Bell — 6-LP box set, Omnivore Recordings (2017)• Labels:Omnivore RecordingsNumero GroupDust-to-DigitalAnalog AfricaCraft RecordingsRhino Records• Artists and People Referenced:Chris Bell — Big Star co-founder; I Am the Cosmos recorded in the mid-1970sBig Star — Memphis power pop band co-founded by Chris Bell and Alex ChiltonGeoff Emerick — engineer and producer; produced and recorded Chris Bell's post-Big Star sessionsEddie Floyd — Stax recording artist and songwriter; known for "Knock on Wood"Johnny Mercer — American lyricist, songwriter, and Capitol Records co-founder; his archive is held at Georgia State UniversityLeonard Cohen — Canadian singer-songwriter; Graves worked on his personal archive• Institutional Archives and Collections:Johnny Mercer Collection — Georgia State UniversityAlan Lomax and George Pullen Jackson Collection of Sacred Harp Music (1942) — Library of CongressSacred Harp singing — WikipediaStax Records — WikipediaStax Museum of American Soul Music• Professional Organizations:The Recording AcademyAssociation for Recorded Sound Collections (ARSC)Audio Engineering Society (AES)The Dust-to-Digital Foundation (Graves is a board member and technical advisor)• Other References:Mobile Fidelity Sound Lab (MoFi) — audiophile reissue label referenced in the source tape discussionThe Sacred Harp Publishing CompanyGrammy Award for Best Historical Album—Dig into this episode's complete show notes at podcast.thetonearm.com—• Did you enjoy this episode? Please share it with a friend! You can also rate The Tonearm ⭐️⭐️⭐️⭐️⭐️ and leave a review on Apple Podcasts. • Subscribe! Be the first to check out each new episode of The Tonearm in your podcast app of choice. • Looking for more? Visit podcast.thetonearm.com for bonus content, web-only interviews + features, and the Talk Of The Tonearm email newsletter. You can also follow us on Bluesky, Mastodon, YouTube, and LinkedIn. • Be sure to bookmark our online magazine, The Tonearm! → thetonearm.com Hosted on Acast. See acast.com/privacy for more information.

Message from Cam Potts on March 8, 2026

The Book of James deals a deck of wisdom, guiding us to live with faith, love, and discernment through actionable teachings, inspired by Proverbs and the Sermon on the Mount. Like a dealer laying out cards, James introduces God's wisdom as a gift, always there during trials, when we need guidance, and when tempted to be selfish or petty. Join Horizon for James: LIVE AND LOVE WISELY, a verse-by-verse study.

The ‘CHATGPT' Of Oncology: How AI Is Bridging The Gap In Cancer Care A person's life expectancy should never be determined by their zip code, yet access to top-tier cancer centers remains a major factor in survival rates. To bridge this gap, a new AI-driven platform is providing patients with expert breakdowns of their specific diagnosis. Our experts this week discuss how this new tool is ensuring all patients have access to the most effective and up-to-date care strategies available. Guests:  Simone Jensen, founder & CEO, Radical Health Elisabeth Drabkin, board member, Radical Health's Patient Advisory Board Host: Elizabeth Westfield Producer: Kristen Farrah     The Patient Playbook: Navigating Billing Systems And Reducing Medical Debt Do you know that you should never pay a medical bill as soon as you receive it? This is just one of many common mistakes patients make that's losing them a lot of money. Our expert this week breaks down how to take control of your financial health and get rid of unnecessary medical debt. Guests: Caitlin Donovan, senior director, Patient Advocate Foundation Host: Greg Johnson Producers: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

 Are you tired of answering the same questions at every consultation? Do you find that prospective patients “go away to think about it” and never return? In this episode of the OMD TV & Podcast Show, Huyen reveals why the secret to faster conversions isn't pushing harder—it's educating smarter. You'll learn how high‑quality, pre‑consultation education turns curious browsers into confident bookers using video explainers, FAQs and compelling testimonials. What You'll Learn Why Pre‑Consult Education Matters: Discover how 70 % of patients make their decision before ever contacting your clinic—and how filling that knowledge gap can dramatically increase bookings. Creating Engaging Video Explainers: Tips for producing 2–5 minute videos that walk viewers through your most popular procedures, answer top questions and showcase behind‑the‑scenes footage. Building a Robust FAQ Library: Learn how to organise and update answers to your most common questions, improve your SEO and help patients self‑qualify. Leveraging Social Proof: Strategies for capturing and sharing patient testimonials (both video and text) to reassure prospective patients that they're in good hands. Designing a Pre‑Consult Education Workflow: Step‑by‑step guidance on automating emails, texts and content delivery so every lead receives the right information at the right time. The Results Clinics Are Seeing: Real-world examples of practices that have doubled their conversion rates, shortened consultation times and boosted patient satisfaction by educating early. Key Takeaways Educated patients convert faster because they arrive informed, confident and ready to proceed. Video, FAQ pages and testimonials are your most powerful tools for building trust before the first consultation. A simple automated workflow (enquiry → thank-you email/SMS → video/FAQ/testimonial sequence → live call) can nurture leads while you focus on delivering care. Clinics that embrace pre‑consult education report higher quality enquiries, more efficient consultations and happier, better‑prepared patients. Resources & Links Ready to build your own pre‑consult education system? Book a free strategy call with OMD: [Discovery Call Link] Learn more about Online Marketing for Doctors   _________________________________________  

Today, we're putting The Tonearm's needle on Michael Graves, a five-time Grammy-winning mastering engineer and the founder of Osiris Studio in Los Angeles.Michael's work is restoration as archaeology—pulling performances off deteriorating tapes, damaged acetates, and obsolete formats, then deciding how much intervention is too much. He's done this for recordings by Hank Williams, Aretha Franklin, Stax songwriters, and field recordings from Cambodia, Sudan, and Mississippi. His most recent Grammy came in 2024 for Written in Their Soul: The Stax Songwriter Demos.The deeper question his work raises is curatorial: where does restoration end and revisionism begin? What gets rescued, and what stays buried?—Dig Deeper• Michael Graves and Osiris Studio:Visit Michael Graves at osirisstudio.com and follow Osiris Studio on InstagramMichael Graves — Osiris Studio: AboutMichael Graves (sound engineer) — Wikipedia• Key Projects Discussed:Written in Their Soul: The Stax Songwriter Demos — 7-CD box set on Craft Recordings (2023), Grammy Award for Best Historical Album (2024)Blondie: Against the Odds: 1974–1982 — box set via Numero Group and UMe (2022)Chris Bell: I Am the Cosmos — definitive reissue on Omnivore Recordings (2017)Chris Bell: The Complete Chris Bell — 6-LP box set, Omnivore Recordings (2017)• Labels:Omnivore RecordingsNumero GroupDust-to-DigitalAnalog AfricaCraft RecordingsRhino Records• Artists and People Referenced:Chris Bell — Big Star co-founder; I Am the Cosmos recorded in the mid-1970sBig Star — Memphis power pop band co-founded by Chris Bell and Alex ChiltonGeoff Emerick — engineer and producer; produced and recorded Chris Bell's post-Big Star sessionsEddie Floyd — Stax recording artist and songwriter; known for "Knock on Wood"Johnny Mercer — American lyricist, songwriter, and Capitol Records co-founder; his archive is held at Georgia State UniversityLeonard Cohen — Canadian singer-songwriter; Graves worked on his personal archive• Institutional Archives and Collections:Johnny Mercer Collection — Georgia State UniversityAlan Lomax and George Pullen Jackson Collection of Sacred Harp Music (1942) — Library of CongressSacred Harp singing — WikipediaStax Records — WikipediaStax Museum of American Soul Music• Professional Organizations:The Recording AcademyAssociation for Recorded Sound Collections (ARSC)Audio Engineering Society (AES)The Dust-to-Digital Foundation (Graves is a board member and technical advisor)• Other References:Mobile Fidelity Sound Lab (MoFi) — audiophile reissue label referenced in the source tape discussionThe Sacred Harp Publishing CompanyGrammy Award for Best Historical Album—Dig into this episode's complete show notes at podcast.thetonearm.com—• Did you enjoy this episode? Please share it with a friend! You can also rate The Tonearm ⭐️⭐️⭐️⭐️⭐️ and leave a review on Apple Podcasts. • Subscribe! Be the first to check out each new episode of The Tonearm in your podcast app of choice. • Looking for more? Visit podcast.thetonearm.com for bonus content, web-only interviews + features, and the Talk Of The Tonearm email newsletter. You can also follow us on Bluesky, Mastodon, YouTube, and LinkedIn. • Be sure to bookmark our online magazine, The Tonearm! → thetonearm.com Hosted on Acast. See acast.com/privacy for more information.

This episode of VHHA's Patients Come First podcast features Tammy Albright, Vice President and Chief Executive Officer for Behavioral Health Services at Ballad Health. She joins us for a conversation about the work to enhance access to behavioral health and substance use treatment across the Appalachian Highlands, including a recently announced Strong Futures residential treatment program for women and families in Norton, VA. Send questions, comments, feedback, or guest suggestions to pcfpodcast@vhha.com or contact on X (Twitter) or Instagram using the #PatientsComeFirst hashtag.

In this episode, Ericka Powell, MD, Vice President of Medical Affairs at WellSpan Ephrata Community Hospital within WellSpan Health, discusses reducing length of stay variation, strengthening physician engagement, and using data driven care pathways to improve quality, workforce stability, and value based performance.

Clinics are feeling the pressure. And one year after the PGT class action lawsuits, the ripple effects are still unfolding.We're back with another Fertility Field Overview, and this one looks at what's happening across patient finance, IVF benefits and third-party reproduction, genetics and diagnostics, and the evolving self-pay landscape.We discuss:Whether IVF benefits managers are helping clinics (or squeezing them)Which lending institutions and loan programs are positioned to rise to the topWhy some say the third-party IVF experience is getting worseWhat's changed in genetics and diagnostics since the PGT lawsuitHow clinics are reducing workload through at-home testing solutionsHow fertility compares to the broader self-pay healthcare marketDive deeper into any of these topics through our Inside Reproductive Health Digest Articles:Patient Finance, Third Party IVF, Genetics, Diagnostics

The Patient Playbook: Navigating Billing Systems And Reducing Medical Debt Do you know that you should never pay a medical bill as soon as you receive it? This is just one of many common mistakes patients make that's losing them a lot of money. Our expert this week breaks down how to take control of your financial health and get rid of unnecessary medical debt. Guests: Caitlin Donovan, senior director, Patient Advocate Foundation Host: Greg Johnson Producers: Kristen Farrah Facebook: ingoodhealthpodX: @ ingoodhealthpodIG: @ingoodhealthpodYouTube: @ingoodhealthpodSpotify Apple Podcast In Good Health PodcastSubscribed to the newsletterFull ArchiveContact UsBecome an Affiliate Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Send a textTo answer this question we must understand the medical model of health care versus a patient centered health care model of care. Support the showSeniorSupportStrategies.com when you need guidance navigating senior care or how to create your own Aging in Place strategy.

Welcome to another episode of TWIRx – This Week in Pharmacy, where we break down the most important developments impacting the pharmacy profession. This week's show features leaders from across community pharmacy, health systems, healthcare advocacy, and international patient engagement. From PBM reform to patient-centered care and health system growth in Western Pennsylvania, this episode brings together voices shaping the future of pharmacy. Sponsored by Sykes & Company, P.A. Accounting, tax strategy, and advisory services dedicated exclusively to independent pharmacy operators. Segment 1 Austin Murray Communications and Marketing Director – Sykes & Company, P.A. We kick off TWIRx with Austin Murray from Sykes & Company, discussing the NCPA Consumer Marketing Campaign designed to educate the public about the value of community pharmacies. Austin shares insights on: • The importance of telling the community pharmacy story directly to consumers • Why independent pharmacies remain essential healthcare access points • The evolving state of independent pharmacy nationwide • Continued momentum around PBM Reform • Strategic accounting and tax advantages pharmacy operators should understand in today's challenging reimbursement environment Austin also explains how pharmacy-focused accounting firms like Sykes & Company help owners navigate reimbursement pressure, tax planning, and business strategy. Segment 2 Mark Duman Pharmacy 50 Award Winner – United Kingdom International healthcare thought leader Mark Duman joins TWIRx to discuss one of the most important principles in healthcare transformation: The patient must come first. Mark shares his perspective on: • Why healthcare systems must remain patient-centered • How pharmacy can lead the way in improving patient outcomes • Lessons learned from patient engagement initiatives in the UK healthcare system • Why meaningful healthcare innovation always begins by focusing on the patient experience Mark emphasizes that when healthcare professionals keep the patient as the constant focus, better pharmacy care and stronger health systems follow. Segment 3 Dr. Laura Mark, PharmD Vice President of Pharmacy – Allegheny Health Network Next, we welcome Dr. Laura Mark, Vice President of Pharmacy at Allegheny Health Network (AHN), who shares exciting news about new pharmacy operations facilities recently built in Butler County, Pennsylvania. Todd and Laura also reflect on their shared roots growing up in Butler County, while discussing how AHN is investing in the future of pharmacy. Topics include: • The new pharmacy operations infrastructure in Western Pennsylvania • How AHN is expanding pharmacy services across the Greater Pittsburgh region • The role of health system pharmacy in improving access to care • Strategic positioning for future healthcare growth and integration AHN continues to strengthen its pharmacy operations as a key component of coordinated patient care throughout the region. Segment 4 Eric Pusey Independent Pharmacy Owner – Pennsylvania Closing out this week's episode, pharmacy owner Eric Pusey joins TWIRx to discuss the latest updates on PBM Reform in Pennsylvania. In 2024, Pennsylvania enacted Act 77, a landmark law aimed at increasing oversight and fairness in pharmacy benefit management. Eric explains how the law: • Grants new regulatory authority to the Pennsylvania Insurance Department • Restricts PBM patient steering to pharmacies owned or affiliated with benefit managers • Improves transparency requirements for PBM operations • Establishes payment protections intended to level the playing field for community pharmacies Patient steering practices have long limited competition and reduced patient choice. Eric shares why these reforms represent an important step toward protecting both patients and independent pharmacy providers across the Commonwealth. Listen & Subscribe Stay informed on the business, policy, and innovation shaping the pharmacy profession. Follow TWIRx – This Week in Pharmacy on the Pharmacy Podcast Network, featuring conversations with the leaders and advocates advancing pharmacy practice.

"The disease is increasingly managed as a chronic condition rather than a diagnosis with an immediate terminal outcome. Particularly, with earlier and more effective and sustained treatment options, we can make this disease a very chronic, long-term, livable condition. I want to make sure that patients are aware that this is not a death sentence. This is something that patients can live with for the long term," Ann McNeill, RN, MSN, APN, nurse practitioner at the John Theurer Cancer Center at Jersey Shore University Medical Center in Neptune, NJ, told Lenise Taylor, MN, RN, AOCNS®, TCTCN™, oncology clinical specialist at ONS, during a conversation about long-term multiple myeloma considerations for oncology nurses. Music Credit: "Fireflies and Stardust" by Kevin MacLeod Licensed under Creative Commons by Attribution 3.0  Earn 0.5 contact hours of nursing continuing professional development (NCPD) by listening to the full recording and completing an evaluation at courses.ons.org by March 6, 2027. Ann McNeill is on the speakers' bureau for Pfizer. This financial relationship has been mitigated. All other planners and faculty for this episode have no relevant financial relationships with ineligible companies to disclose. ONS is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. Learning outcome: Learners will report an increase in knowledge related to management of long-term side effects related to multiple myeloma and treatment. Episode Notes  Complete this evaluation for free NCPD.  ONS Podcast™ episodes: Episode 401: Multiple Myeloma Treatment Considerations for Oncology Nurses Episode 398: An Overview of Multiple Myeloma for Oncology Nurses Episode 339: A Lesson on Labs: How to Monitor and Educate Patients With Cancer Episode 201: Which Survivorship Care Model Is Right for Your Patient? ONS Voice articles: Effective Care Transitions Are Essential for New Multiple Myeloma Treatments Infection Prevention for Oncology Nurses Multiple Myeloma Prevention, Screening, Treatment, and Survivorship Recommendations Nurse-Led Survivorship Programs Sexual Considerations for Patients With Cancer Oncology Nursing Forum articles:  A Qualitative Study of the Experiences of Living With Multiple Myeloma Changes in Health-Related Quality of Life During Multiple Myeloma Treatment: A Qualitative Interview Study ONS book: Multiple Myeloma: A Textbook for Nurses (third edition) ONS Huddle Cards: Pain Management Sexuality Survivorship Care Plan ONS Learning Libraries: Hematology, Cellular Therapy, and Stem Cell Transplantation Survivorship ONS Symptom Intervention resources: Chronic Pain Fatigue Peripheral Neuropathy American Cancer Society: Living as a Multiple Myeloma Survivor Blood Cancer United: Resources for Healthcare Professionals International Myeloma Foundation: Resources and Support for the Myeloma Community Multiple Myeloma Research Foundation: Empower Patients and the Community To discuss the information in this episode with other oncology nurses, visit the ONS Communities.  To find resources for creating an ONS Podcast club in your chapter or nursing community, visit the ONS Podcast Library. To provide feedback or otherwise reach ONS about the podcast, email pubONSVoice@ons.org. Highlights From This Episode "We do consider myeloma an incurable hematologic malignancy, even though we have had improvements in survival. But just like for any malignancy, our goal is to maximize survival. We want to eliminate as many myeloma cells as we possibly can. And subsequently, we want to improve the quality of life for these patients in the long term. So those are basically our treatment goals. That's what we think of when we're treating patients all throughout their treatment journey." TS 1:39 "It is very typical for patients along their journey to have received several lines of therapy. I think it's important to realize that the cells acquire new mutations, making them more resistant to these further subsequent lines of therapy. We see quicker, more aggressive relapses in those patients with multiple prior lines of therapy. We can see an increase in the CRAB symptoms, which are the calcium elevations, the renal dysfunction, profound anemia, and even bone disease. We can see a rapid rise in the monoclonal protein in the labs or even a very rapid rise in the involved light chain in that serum free light chain assay, so it's important to monitor these labs." TS 9:14 "All oncology nurses are focusing on these survivorship plans now. And I think that's a great thing when you think about a diagnosis of cancer and a survivorship plan, because it means these patients are living a longer time. We still look at long-term health maintenance guidelines depending on the patient's sex and their age. ... I think preventing infection is always going to be something absolutely on the forefront in our survivorship plan with myeloma. I mean, myeloma is an immune system malignancy. The treatments that we have given patients can sometimes, especially in later life therapies, further compromise the immune system. So, we're always looking to prevent serious infection." TS 12:46 "Patients get treatment, especially induction therapy. They may or may not get transplant. They may have been on a very minor maintenance schedule, depending on their age. And they feel really well. And then they decide not to return for their follow-up because they feel so good. I think nurses are critical in the communication aspect of the patient-provider aspect. So, nurses are really the key means of communication. The providers are absolutely important—the physicians, the nurse practitioners and every other member of the team—but I think the nurses have a really special rapport with patients. They're usually the ones providing the education on the treatment regimens. They're managing the toxicity profiles. They're doing all the coordination of care between visits. They are really going to be the ones telling the patient, 'Hey, you're going to feel good and that's a wonderful thing, but you still need to come once a month or once every six weeks or once every two months for your labs.'" TS 15:17  "It has been amazing. The science, the research, the treatments, the approvals from the U.S. Food and Drug Administration. Survivorship has improved dramatically. Let's take the first few years of the new century, right? The five-year survival rate was about 38%. If you then jump to 2015–2019, which is still seven plus years ago, it has doubled. So, we're talking about anywhere from 60%–80% over a five-year survival. So that's an amazing improvement in their five-year survival rate for myeloma." TS 23:28 "Survivorship in myeloma begins at diagnosis, not just after treatment. And I think that because it is managed as a chronic, often relapsing disease, it does require lifelong evolving care. Patients should realize that they will know us for the rest of their lives. We will know everything about you. I always tell them, 'I will know everything about your hobbies, your children, your grandchildren, what you love to do on the weekends.' It's very important that that point is made right at diagnosis, not just after so many lines of treatment. It's very important that we are going to follow these patients throughout their journey." TS 28:18

JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin discuss "Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?" Related Content: Are AI Tools Ready to Answer Patients' Questions About Their Medical Care?

In this podcast, experts Ashish M. Kamat, MD, MBBS, Katie S. Murray, DO, MS, and Thomas Powles, MD, MBBS, MRCP, discuss the classification of BCG responsiveness and intravesical and systemic therapies for non-muscle invasive bladder cancer.

Episode 215: Meth-associated HFrEF.   Abishak and Zat (medical students) explain the cardiotoxic effect of methamphetamine and the diagnosis and treatment of heart failure with reduced ejection fraction (HFrEF). Dr. Arreaza adds insight into the reversibility of meth-associated HFrEF.   Written by Abishak Govindarajan, MSIV and Zat Akbar Shaw. American University of the Caribbean. Edits and comments by Hector Arreaza, MD. Welcome Dr. Arreaza: Welcome to Rio Bravo qWeek. My name is Hector Arreaza, family physician, faculty and associate program director of the Clinica Sierra Vista/Rio Bravo Family Medicine Residency Program. Today we will explore heart failure with reduced ejection fraction, a high-yield and clinically relevant topic in medicine. We will discuss the role of methamphetamine use in the development of HFrEF. This is a pressing issue because about 0.8% of the population 12 and older in the US reported using methamphetamine within the past 12 months in 2024 (National Survey on Drug Use and Health, NSDUH), that's about ≈2.4 million people!We are joined by two aspiring physicians who will help explore this topic. By the way, we will refer to methamphetamine in this episode as “meth”. [Abishak and Akbar introduce themselves] Abishak: [Introduce yourself] The role of meth in HFrEF Dr. Arreaza: Meth is a growing problem in many places, including Bakersfield, where we live. Meth is also known as Meth Crystal, Poor man's cocaine, Ice, Glass, Crank, Speed, Chalk, and Tina. How does meth contribute to the development of HFrEF? Abishak: So, first, let's understand how methamphetamine works. It has a chemical structure similar to dopamine and norepinephrine, and it gets taken up through the neuron transporter proteins. Once it enters the synaptic vesicles (storage sacs for neurotransmitters), it displaces and forces the release of large amounts of dopamine, norepinephrine, and serotonin into the synapse (the space between neurons). Additionally, meth blocks the reuptake of those neurotransmitters into the neuron, ensuring they remain in the synapse for a prolonged period. All this causes a downstream effect of increased sympathetic pathways in the body. Diagnosis Dr. Arreaza: The diagnosis starts with collecting a good history and performing a complete physical exam, and then we confirm with an echocardiogram.  Abishak: Yes, diagnosis requires both symptoms consistent with heart failure and objective evidence of reduced ejection fraction. Echocardiography is the primary diagnostic tool. We also measure BNP. In certain cases, cardiac MRI is used to evaluate myocardial fibrosis and exclude infiltrative or inflammatory etiologies. Coronary angiography may be performed if ischemic disease is suspected.Guideline-Directed Medical Therapy Dr. Arreaza: GDMT Guideline-Directed Medical Therapy started around 1987 when ACE inhibitors were proven to improve mortality in patients with heart failure. Then, during the following decades, many medications have been added to GDMT. Until around 2019–2022 we came out with the main 4 groups of medications that we know as GDMT. Let's talk about GDMT. Akbar: There are four core pillars in GDMT. First, an angiotensin receptor-neprilysin inhibitor, such as sacubitril with valsartan (Entresto), is preferred over ACE inhibitors when tolerated. This medication reduces mortality and heart failure hospitalizations. Second, evidence-based beta blockers including carvedilol, metoprolol succinate, or bisoprolol are used to reduce sympathetic overactivity and improve ventricular remodeling. Third, mineralocorticoid receptor antagonists such as spironolactone or eplerenone reduce fibrosis and improve survival. The Fourth pillar is SGLT2 inhibitors such as dapagliflozin or empagliflozin, which provide significant reductions in heart failure hospitalizations and cardiovascular mortality, regardless of diabetes status. Abishak: Other main parts of the treatment are diuretics, which are used for symptom control but do not reduce long-term mortality. Dr. Arreaza: As a recap: The current 4 pillars of GDMT are: ARNI/ACEi + β-blocker + MRA + SGLT2i)  Beta Blocker Considerations Dr. Arreaza: Sometimes we may be concerned about using beta blockers in active meth users. What did you read about it? Abishak: Historically, there was concern about unopposed alpha stimulation. However, in chronic heart failure, beta blockers remain essential. Carvedilol is often favored because it provides both alpha and beta blockade. Careful titration and close monitoring are critical.Reversibility and Remodeling Dr. Arreaza: Regarding meth-associated HFrEF, we have good news for meth users. Tell us about how reversible this condition is.  Akbar: It can be reversible. One of the most important aspects of this condition is that significant reverse remodeling may occur if the patient stops methamphetamine use and adheres to medical therapy. The Left ventricular ejection fraction can improve substantially and, in some cases, normalize. On the other end of the spectrum, continued meth use may lead to progressive fibrosis, ventricular dilation, and potentially irreversible damage, leading to death.Complications of meth-associated HFrEF Abishak: These patients are at increased risk for ventricular arrhythmias, sudden cardiac death, left ventricular thrombus formation, and progressive pulmonary hypertension. If the ejection fraction remains below 35 percent after at least three months of optimized therapy, implantable cardioverter-defibrillator (known as ICD) placement should be considered for primary prevention.Addiction Treatment as Core Therapy Dr. Arreaza: It sounds like GDMT cannot be done without talking about meth use disorder treatment. Akbar: Absolutely. Treating the myocardium without addressing the substance use disorder is ineffective. Primary care providers can be trained to manage addictions, but if resources are available, you can place a referral to addiction medicine, psychiatric support, behavioral therapy, and social support services. This is an essential part of the treatment. Sustained abstinence is the single most powerful predictor of recovery.Prognosis Abishak: Prognosis is highly dependent on abstinence. Patients who stop using methamphetamine often experience meaningful improvement in EF and even return to normal.  Dr. Arreaza: Yes, the key factor is complete abstinence, plus standard heart failure treatment. If the damage is mostly functional and inflammatory, recovery is possible. If there is extensive fibrosis (scar) recovery is less likely. Observational studies have shown that patients with meth-associated cardiomyopathy who stop using meth have significant improvement in EF over 3–12 months, fewer hospitalizations, and lower mortality. Akbar: Absolutely. Not all meth-associated cardiomyopathy behaves the same way. The extent of fibrosis determines recovery potential. Cardiac MRI with late gadolinium enhancement can help us estimate scar burden. Patients with minimal fibrosis often have better improvement with abstinence and medical therapy. Dr. Arreaza: So, MRI can actually help us determine the prognosis. Abishak: Yes, very much so. If MRI shows extensive fibrosis, the likelihood of full EF recovery is lower. That information helps us counsel patients more accurately. Akbar: Another key issue is right ventricular involvement. Methamphetamine can affect both ventricles. When the right ventricle fails, patients may develop severe peripheral edema, ascites, and hepatic congestion. Right ventricular dysfunction also worsens prognosis significantly. Dr. Arreaza: And pulmonary hypertension can also worsen the whole picture.  Akbar: That's correct. Meth is associated with pulmonary arterial hypertension independently of left-sided heart failure. In some patients, you may see a combined picture of both pulmonary vascular disease and right ventricular dysfunction. That can make management more complicated because pulmonary pressures may remain elevated even after EF improves. Dr. Arreaza: Tells us about the role of BNP in monitoring these patients.  Abishak: Serial BNP levels can help track response to therapy. Additionally, troponin may be elevated at times in meth users due to myocardial injury. Monitoring renal function is critical because many heart failure medications affect kidney function and potassium levels. Akbar:Other lifestyle modifications include sodium restriction, regular follow-ups, vaccination, and avoidance of other cardiotoxic substances such as alcohol or cocaine. Sleep disorders, especially OSA, should be evaluated because untreated OSA worsens heart failure outcomes. Dr. Arreaza: WhatIs there any role for wearable devices or remote monitoring? Abishak: Yes, increasingly so. Remote weight monitoring, blood pressure tracking, and symptom reporting can reduce hospitalization. In select patients, implantable hemodynamic monitors may help detect rising filling pressures before symptoms occur. Dr. Arreaza: It was a great discussion. Thank you, Abishak and Akbar for bringing all that valuable information to us. Let's wrap it up.     

Patients are saying "I'll think about it" more than ever — not because they don't want care, but because they can't see how to afford it. In this episode, Dr. Len Tau and Nancy Coy break down how dental practices can rebuild trust, improve the money conversation, and create a clear path from diagnosis to a confident "yes." Dr. Len Tau sits down with Nancy Coy of FinanceRx to talk about what really causes case acceptance breakdowns. They discuss why affordability is the #1 barrier for patients, how practices should structure lending options beyond just one provider, and why the money conversation must start earlier in the patient journey — even before the patient walks in. Nancy also shares compliance risks practices often overlook, and Dr. Len explains how offering the right financing at the right time can turn patients into lifelong raving fans.   What You'll Learn Why affordability is the biggest reason patients delay treatment How to respond when teams resist financing because of "fees" The difference between revolving credit vs installment loans When and how the money conversation should happen in the patient journey Why having multiple lenders (by credit tier and case size) matters The compliance pitfalls that can hurt your reputation and revenue How trust and transparency can dramatically increase case acceptance   Key Takeaways 00:44 Welcome and Sponsors 03:20 Nancy's Career Journey 05:40 Affordability Blocks Treatment 10:56 Diagnosis to Decision Gap 13:20 Building Patient Trust 18:10 Presenting Without Selling 22:10 Credit and Compliance 23:47 Smarter Lending Strategy 29:56 Avoiding Regulatory Risk 34:51 Inside FinanceRx 36:24 Lightning Round 39:20 Final Takeaways   — Connect with Nancy

In this episode, Ericka Powell, MD, Vice President of Medical Affairs at WellSpan Ephrata Community Hospital within WellSpan Health, discusses reducing length of stay variation, strengthening physician engagement, and using data driven care pathways to improve quality, workforce stability, and value based performance.

From WEDI's 2026 Winter Forum, Michael chats with three payer representatives who discuss how access APIs are improving the patient experience by making data easier to access, use, and share across care journeys. Tom Loomis, Enterprise Architecture- Interoperability, Evernorth Nancy Bevin, Director, Provider Connectivity, Medica Ron Wampler, Executive Director, Interoperability, Aetna, a CVS Health Company

Trauma-informed care plays a critical role in functional medicine. Trauma can affect patient outcomes. This episode provides actionable insights for clinicians to create a more trauma-aware practice, highlighting the need for self-awareness and personal healing among healthcare providers to better support their patients.   Highlights: Trauma can significantly impact clinical outcomes, even with correct protocols. Patients often come with a history of medical trauma, affecting their engagement. The clinician's own trauma work is essential for effective patient care. Creating a safe and nurturing environment is crucial for patient healing. Recognizing different trauma responses in patients can guide treatment approaches.   Links:   Catalyst Studio: https://drlarasalyer.com/catalyst Brainstorming session: https://drlarasalyer.as.me/discovery Membership Practice Jumpstart Workshop Eventbrite: https://www.eventbrite.com/e/membership-practice-jumpstart-tickets-1981907451539?aff=oddtdtcreator The book 90 Seconds to a Life You Love:  https://a.co/d/02hRL3fH   Connect with Lara: Website: https://drlarasalyer.com Apple Podcasts: https://podcasts.apple.com/us/podcast/the-catalyst-way-creative-strategies-for-women-in/id1611612131  Spotify: https://open.spotify.com/show/7d96T0XY32NxEefslXhLNo?si=90609a4ca6254dec  https://www.instagram.com/drlarasalyer/  https://www.facebook.com/drlarasalyer https://www.linkedin.com/in/drlarasalyer/ https://www.tiktok.com/@Creativity.Doctor

If you've ever thought, “Why didn't anyone prepare me for this?” — this episode is for you. So many women are doing all the “right” things, yet still feel exhausted, inflamed, foggy, or just off in ways they can't quite explain. Too often, we're told it's simply part of aging.   In this episode of HEAL with Kelly, I'm joined by Dr. Amy Shah, whose work — and new book, Hormone Havoc — is helping change the conversation around women's health. We talk about why women's health has been historically overlooked, how nutrition has been left out of critical medical education, and why so many women feel dismissed when they seek real answers — especially during perimenopause and menopause.   Dr. Shah explains how hormonal shifts affect the brain, gut, metabolism, mood, and nervous system — and why symptoms like hot flashes, night sweats, brain fog, cravings, and poor sleep are signals, not failures. We explore simple, science-backed ways to support hormones through food, movement, and lifestyle, including walking, strength training, gut health, stress resilience, and why alcohol affects women differently in midlife.   We also talk about purpose, community, and connection, and why women are evolutionarily wired to thrive in this next phase of life.   If you've been searching for clarity, validation, or a more compassionate roadmap for this chapter, this episode offers exactly that. Key Moments You'll Love ✨:

Dr. Barbara Paldus is the Founder and CEO of CODEX Labs, the sponsor of this episode.She grew up around Nobel Prize winners, built biotech manufacturing equipment for vaccines and cancer therapeutics, and then sold her company after an 8 year old threatened suicide.Her son's severe eczema pushed her into an unregulated $100,000,000,000 skincare market where parents are told to trust labels that nobody verifies. She explains how corticosteroid ladders leave patients with years long withdrawal, why U.S. ingredient oversight lags Europe, and how chemotherapy destroys the same skin and gut barriers seen in inflammatory disease.The conversation tracks the real stakes behind “clean” marketing: a child's immune system, hospital infections like MRSA, and patients trying to survive treatment without new damage. She also details the research path from Irish medical manuscripts to microbiome science and why sick populations become the only reliable regulators when policy fails.RELATED LINKSBarbara PaldusCodex LabsSekhmet VenturesDr Peter LioFEEDBACKLike this episode? Rate and review Out of Patients on your favorite podcast platform. For guest suggestions or sponsorship email podcasts@matthewzachary.comSee Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

An unassuming house in Southeast Portland’s Buckman neighborhood was recently added to the National Register of Historic Places. Once known as “Juniper House,” the building served as one of the first end-of-life care homes for AIDS patients in the Pacific Northwest in the late 1980s. An OPB documentary at the time explored the lives of some of the patients in Juniper House and the neighboring Assisi House, which provided a range of care for patients with HIV/AIDS. Jan Weyeneth is one of the co-founders of Juniper House. Cayla McGrail is a former associate project manager for Portland’s LGBTQ+ Historic Sites Project, which sponsored the house’s listing. We first spoke with Weyeneth and McGrail in April 2025 about Juniper House and the importance of documenting queer history in Portland.

What if a warm welcome and a personal touch could be the most powerful tools for growing your dental practice?In this episode, Dr. Allon reveals how her journey from corporate dentistry to solo practice was powered by a desire for meaningful patient relationships, family support, and a relentless commitment to hospitality. She shares the step-by-step systems her Clear Lake office uses to maximize comfort and efficiency, from five-minute patient intake to comprehensive 90-minute new patient exams and personal follow-up calls after treatment. Dr. Allon also reflects on the behind-the-scenes grit required to launch her practice: navigating unexpected DIY build-out challenges, winning initial patients through strategic signage and ground marketing, and fostering a collaborative, no-ego team culture that attracts both patients and staff. Whether you're considering the leap into private practice or want inspiration on building trust and visibility, you'll find practical insight and encouragement in Dr. Allon's candid story.What You'll Learn in This Episode:The transition from corporate dentistry to starting a solo practiceHow to design a hospitality-driven patient flow that stands outWhy thorough new patient visits build lasting trust and referralsStrategies for marketing your practice with visibility (not just ads)Practical tips for juggling practice ownership with family lifeLessons learned from running your own office build-out on a tight budgetThe impact of personal follow-up calls and ground marketing techniquesHow to foster a team culture without egos or micromanagementOvercoming unexpected challenges during a post-pandemic openingWhy investing in patient relationships leads to rapid growthJoin us for a behind-the-scenes look at how real, patient-focused dentistry can transform your practice and your community!‍(This episode originally aired on 1/18/2024)‍Sponsors:‍Oryx: All-In-One Cloud-Based Dental Software Created by Dentists for Dentists. Patient engagement, clinical, and practice management software that helps your dental practice grow without compromise. Click or copy and paste the link here for a special offer! https://thedentalmarketer.lpages.co/oryx/Net32: Founded by a dentist, for dentists. Net32 is the leading online marketplace for dental supplies, helping dental and medical professionals save on high-quality products for over 25 years. Start saving today at: https://www.net32.com/dentalmarketer‍Guest: Dr. Liel AllonPractice Name: DentAllon DentistryCheck out Liel's Media:Practice: https://www.dentallondentistry.com/Instagram: https://www.instagram.com/dentallon_dentistry/‍Host: Michael AriasJoin my newsletter: https://thedentalmarketer.lpages.co/newsletter/‍Join this podcast's Facebook Group: The Dental Marketer Society‍Love the Podcast? Subscribe on Your Favorite App! https://lnkfi.re/TDMPod

See if you qualify for our 100% Done-For-You YouTube service: https://go.healthpreneurtraining.com/youtube?el=growpractice-youtubeIf you're growing your practice on referrals alone, you're one dry spell away from struggling.The #1 way to grow a private practice in 2026 has nothing to do with networking, Google ads, or Instagram.It's YouTube. And most practitioners are completely ignoring it.I've been building health businesses online for 20 years. My first was built on a 300,000-subscriber YouTube channel. It helped half a million people, led to a NYT bestselling book, and put me on The Doctors and Dr. Oz. As CEO of Healthpreneur, I've helped thousands of practitioners scale to 6, 7, and 8 figures. Here's why I'd go all-in on YouTube if I were starting a practice today.⏱️ Timestamps:00:00 The #1 way to grow your private practice in 202600:37 Why referral-dependent practices become the best-kept secret00:57 The trust recession: why patients don't know who to trust01:40 Reason #1: How YouTube builds trust faster than any other platform02:43 YouTube vs. Instagram/TikTok: 40-minute sessions vs. 15 seconds05:11 The best expert doesn't win. The best known expert does.06:56 Reason #2: YouTube users have the highest household income of any platform07:50 The stats: 87% of US YouTube users earn $70K to $100K per year09:03 Reason #3: The YouTube Health Source Certification advantage10:47 How the certification gives licensed practitioners priority in search12:41 Why Google AI and Gemini reference YouTube as the #1 health source14:23 How YouTube videos compound into a 24/7 patient acquisition flywheel❓ QUESTIONS ANSWEREDQ: How do I grow my private practice without relying on referrals?A: Build a YouTube channel around the conditions you treat. Patients searching for those problems will find you and trust you before they ever reach out. (01:40)Q: Why is YouTube better than Instagram or TikTok for a health practice?A: YouTube sessions average 40 minutes vs. 15 seconds on TikTok. No one chooses a practitioner from a short reel, but they will after watching several of your videos. (02:43)Q: What is the YouTube Health Source Certification for practitioners?A: Licensed practitioners who reach 1,500 watch hours can apply for a verified badge. It gives their content priority over unqualified influencers in health searches. (09:03)Q: Are YouTube users actually good prospects for a health practice?A: Yes. 87% of US YouTube users earn $70K to $100K per year and 89% hold a college degree. It's the most educated, highest-income audience on any social platform. (07:50)Q: How long does it take for YouTube to start bringing in patients?A: It builds like an asset. Early videos get little traction, but over time they create a 24/7 flywheel of patients finding and trusting you. (14:23)

On this week's 300th episode: Morris makes a bet that the ER will take in 300 patients before the next shift comes in, Julia leads the staff in a blessing ceremony, Sam's transport training goes sideways after her ambulance is in an accident, Neela has to swab a camel's mouth after it bites Dubenko, Pratt helps a family after a wife and son are in a bad car accident, and Abby's finally reveals her drinking to Luka as they prepare to go to Croatia.   

What happens when 50 million people need endocrine care… but there are only about 4,000 practicing endocrinologists to see the complex cases? In an environment where misinformation is everywhere and specialist capacity is limited, how can an association help clinicians and care teams deliver better outcomes at scale without diluting quality?In this episode of Associations Thrive, host Joanna Pineda interviews Johnnie White, CEO of the American Association of Clinical Endocrinology (AACE). Johnnie discusses:How AACE's membership is ~6,000 worldwide, with predominantly physicians and a growing “endocrine care team” that includes NPs, PAs, pharmacists, and primary care clinicians.The sobering workforce math: “there's not enough endocrinologists” for the volume of diabetes (and other endocrine disorders), and why AACE prioritizes educating the broader care team.How members get access to endocrine-specific education, guidelines, publications, and networking with field experts.The strategic shift from “endocrinologists” to “endocrinology” and how a bigger tent supports care delivery while keeping endocrinologists as the clinical leaders who develop guidelines.AACE's patient-first digital strategy: landing visitors on the patient portal first, then routing clinicians to the healthcare/member portal.How AACE built “patient journeys” (diabetes, thyroid, obesity, and more) to counter misinformation and provide understandable, trustworthy guidance for patients and caregivers.Why AACE's patient content is heavily used not only by patients but also by clinicians who refer patients to it for education and reinforcement.The organization's non-traditional education mix, including podcasts as an accessible channel for timely topics, and microlearning with short modules, tracked for continuing education credit.Johnnie's leadership philosophy, “Mamba Mentality,” is a continuous quest to improve, seek feedback, and empower experts on the team.References:AACE Website

Our guest today is Pam Cusick Senior Vice President of Rare Patient Voice. Rare Patient Voice is a national community that connects patients and caregivers with researchers who genuinely want to learn from their lived experiences. Through this work, RPV ensures that people living with rare and chronic conditions have a direct voice in shaping studies, treatments, and health innovations. Their model is built on trust, respect, and fair compensation, creating a space where stories become data that can drive meaningful change. Pam Cusick is a leader in patient engagement with more than three decades of experience in research design, implementation, and advocacy. As Senior Vice President of Rare Patient Voice (RPV), she works to ensure that patient and caregiver experiences help shape the future of medical research. Beyond RPV, Pam contributes to the advancement of women in healthcare through her work with Women in Research (WIRe), the Healthcare Businesswomen's Association (HBA), and the International Society for Patient Engagement Professionals (ISPEP). She continues to mentor emerging leaders who share her dedication to connecting patient advocacy with meaningful scientific progress.

Drs. Vakharia and Danzig highlight new AAO 2025 data on high-dose aflibercept, sleep apnea as a potential AMD risk factor, and an AI-guided anti-VEGF regimen that cuts injections while maintaining vision. Together, these advances point toward more personalized, efficient care for patients with neovascular AMD and DME.

In this episode of Derms and Conditions, host James Q. Del Rosso, DO, welcomes David Seiter, FNP-C, for a wide-ranging discussion on challenging dermatologic dogma and integrating emerging evidence into clinical decision-making. They begin with Seiter sharing his approach to reviewing new literature, encouraging clinicians to look beyond mainstream dermatology journals to cross-disciplinary publications to help reshape long-held assumptions. Using lichen planus as an example, he revisits the entrenched association between diffuse lichen planus and hepatitis C. While many clinicians routinely test for hepatitis C in these patients, new data suggest the association is uncommon. More compelling, however, is the emerging link between persistent, widespread lichen planus and underlying malignancy. Seiter outlines how he thoughtfully screens for red flags and gaps in preventive care without alarming patients prematurely, reinforcing the importance of looking beyond a single lab test. The conversation then shifts to acanthosis nigricans, where traditional teaching centers on hyperglycemia and diabetes risk. Seiter explains why acanthosis nigricans is more accurately viewed as a marker of hyperinsulinemia rather than elevated A1c. He discusses incorporating HOMA-IR calculations to identify early insulin resistance, particularly in adolescents whose A1C may remain normal for years. Both clinicians stress that a “normal” A1C should not prematurely reassure patients when cutaneous markers signal metabolic risk. Additional topics include reconsidering intralesional triamcinolone as the default therapy for keloids, with discussion of emerging data on intralesional insulin as a potentially lower–adverse event alternative, and a pragmatic conversation about JAK inhibitor safety. Comparing adverse event data across agents, they emphasize individualized risk assessment, careful monitoring, and shared decision-making over reflexive fear of boxed warnings. Tune into the episode to explore how questioning assumptions, broadening your literature review, and contextualizing risk can sharpen your clinical reasoning and elevate patient care in everyday dermatology practice.

Drs. Jennifer Weller and Shamieh Banihani discuss the article "Patient- and Institution-Level Factors Associated With Intraoperative Cardiac Arrest During Major Noncardiac Surgery" published in the March 2026 issue of Anesthesia & Analgesia.

Do you know that we can learn more about God by studying His attributes and character? Listen today as  we talk through God's character and how this can and should  encourage us in our everyday lives. Unshaken Episodes on God's Attributes: Ep 168: God is Gracious with Jackie LongEp 174: God is Faithful with Jules BartlettEp 178: God is Good with Lexie RuizEp 183: God is Generous with Stephanie BlossEp 196: God is Independent with Maddie KreuzEp 198: God is Patient with Mackenzie AhrendtEp 205: God is Sovereign with Andrea Van EngenReach out at:unshakenpsalm622@gmail.comChurch History by Christ The Word Church - PodcastFellow Heirs - Podcast

In this episode of The Thriving Dentist Show, Gary Takacs and Naren Arulrajah tackle one of the biggest hidden profit leaks in dentistry. Unscheduled treatment plans. They explain why many dental practices have thousands of patients in their database but only a small number who move forward with recommended care. You will learn why patients say no to treatment, how to create real interest instead of pushing solutions, and why showing clear photos can increase case acceptance. Gary shares simple text message scripts that work better than phone calls, how far back you should go when following up on incomplete treatment, and why every practice needs a weekly system to track and schedule pending dentistry. If you want to increase treatment acceptance, boost production without adding more new patients, improve patient follow up, and build a stress free dental practice with strong systems, this episode gives you clear, practical steps you can use right away. For a complimentary Marketing Strategy Meeting visit ekwa.com/td and for a Coaching Session with Gary visit thrivingdentist.com/csm

This week, we explore a phase 3 trial of finerenone in type 1 diabetes and chronic kidney disease and guidance on timing of nonculprit-lesion PCI after STEMI. We cover an investigational therapy for Dravet syndrome and neoadjuvant treatment for high-risk intrahepatic cholangiocarcinoma. We review the effects of radiotherapy on normal tissue, a puzzling case of progressive neurologic decline after suspected foodborne illness, and Perspectives on private equity, the AHEAD model, and medical credit cards.

In this episode, we share how to confidently give patients clear choices in the exam lane without creating confusion or pushback around vision and medical care. We explain how setting expectations early and taking ownership of clear communication builds trust and increases acceptance of follow up visits. We also touch on how to structure your schedule to support shorter, more frequent visits and why giving patients ownership of their decisions improves both the patient experience and practice profitability.   Hosted By Adam Cmejla, CFP and Chad Fleming, OD, FAAO Have a question? Submit it here Subscribe on Apple Podcasts: https://shorturl.at/Fq1Ro  Subscribe on Spotify: https://shorturl.at/jCtsk    The Optometry Success Podcast, hosted by Adam Cmejla, CFP and Chad Fleming, OD, FAAO helps private-practice optometrists build profitable, sustainable businesses with clarity and confidence. Hosted by Adam Cmejla, CFP—a financial planner and CFO to ODs nationwide—and Dr. Chad Fleming, OD—a multi-location practice owner with decades of hands-on experience—each 20-minute episode delivers practical strategies and actionable insights you can apply right away. From leadership and financials to team culture, operations, and growth, this is your weekly dose of real-world advice for real-world practice owners. New episodes every Wednesday.   Please be sure to subscribe to The Optometry Success Podcast on Apple Podcasts and Spotify now to check out the next two episodes right now!   The Optometry Success Podcast  Subscribe on Apple Podcasts: https://bit.ly/4tttng6 Subscribe on Spotify: https://bit.ly/4tuf0YM        Resources: Book a Triage call with Adam Download the Practice Owner's Financial Toolkit 20/20 Money Ultimate Financial Success Masterclass OD Mastermind Interest Form   ————————————————————————————— Please rate and subscribe to 20/20 Money on these platforms Apple Podcasts Spotify ————————————————————————————— For past episodes of 20/20 Money with full companion show notes, please check out our episode archive here!

In this episode, Steve Smith, Assistant Vice President of Enterprise Contact Center and Access at Inova Health System, shares how the organization is leveraging cloud based technology, digital assistants, and AI driven tools to streamline scheduling, improve self service, and enhance both patient and team member experiences.

Kamaldeep Bhui is Professor of Psychiatry at the University of Oxford and Honorary Professor at Queen Mary University of London. He is internationally recognized for his groundbreaking work on cultural psychiatry, ethnic inequalities in mental health, and the social determinants of distress. In recognition of his contributions to mental health research and policy, he was appointed Commander of the Order of the British Empire (CBE). He has written extensively on the grim reality of minorities facing higher rates of psychiatric detention and coercion. In an era of algorithmic checklists and time-pressured care, Bhui argues for reclaiming biographical listening and patients' own stories and understandings. Without cherishing lived experience, clinicians lose meaning in their work and patients lose agency, trust, and hope. In this interview, we will discuss how our contexts and culture reach deep within us to inform our experience of pain, and to indicate what is abnormal, why we feel distress, and what it means to heal. *** Thank you for being with us to listen to the podcast and read our articles this year. MIA is funded entirely by reader donations. If you value MIA, please help us continue to survive and grow. https://www.madinamerica.com/donate/ To find the Mad in America podcast on your preferred podcast player, click here: https://pod.link/1212789850 © Mad in America 2026. Produced by James Moore https://www.jmaudio.org

In this episode of Business School for the Rehab Chiropractor, Justin speaks with Dr. Derek Huddleston (clinic owner in Little Rock, Arkansas) whose path to practice ownership was forged through extreme hardship and a decision to build a clinic that actually listens.As an Air Force veteran and former medic, Derek shares how losing people close to him, navigating addiction, and watching the “pill-first” system fail pushed him toward chiropractic and a rehab-based model. Justin and Derek unpack what happens when you stop chasing volume, start charging based on value, and take 100% ownership of your outcomes, especially in a market where people assume “that price won't work here.” In this episode, you'll hear about:How Derek went from high-volume practice pressure to a values-driven rehab chiro modelWhy conviction and empathy matter more than scripts when it comes to “selling” care plansThe “small town” pricing myth and how Derek sells $5,600 care plans in a $45K income marketYour Host: Justin RabinowitzFounder of RehabChiro Coach.Justin works with chiropractors and clinic owners to build profitable, scalable practices rooted in clear business models and disciplined execution.To learn more about how Justin and Rehab Chiro Coach can help you finally build the business of your dreams, click here to book a free strategy call with his team.To get your first month free with Jane.app, use my code Rehabchiro1moClick here to book your demo

Katie Beth Hand shares her journey as Patient Nine in the Eledon clinical trial, receiving donor islet cells and a targeted immunotherapy that may functionally cure her type 1 diabetes. Free Juicebox Community (non Facebook) Eversense CGM Medtronic Diabetes Tandem Mobi ** Use code JUICEBOX to save 40% at Cozy Earth  CONTOUR NextGen smart meter and CONTOUR DIABETES app Dexcom G7 Go tubeless with Omnipod 5 or Omnipod DASH * Get your supplies from US MED  or call 888-721-1514 Touched By Type 1 Take the T1DExchange survey Apple Podcasts> Subscribe to the podcast today! The podcast is available on Spotify, Google Play, iHeartRadio, Radio Public, Amazon Music and all Android devices The Juicebox Podcast is a free show, but if you'd like to support the podcast directly, you can make a gift here or buy me a coffee. Thank you! *The Pod has an IP28 rating for up to 25 feet for 60 minutes. The Omnipod 5 Controller is not waterproof.  ** t:slim X2 or Tandem Mobi w/ Control-IQ+ technology (7.9 or newer). RX ONLY. Indicated for patients with type 1 diabetes, 2 years and older. BOXED WARNING:Control-IQ+ technology should not be used by people under age 2, or who use less than 5 units of insulin/day, or who weigh less than 20 lbs. Safety info: tandemdiabetes.com/safetyinfo Disclaimer - Nothing you hear on the Juicebox Podcast or read on Arden's Day is intended as medical advice. You should always consult a physician before making changes to your health plan.  If the podcast has helped you to live better with type 1 please tell someone else how to find it!